11:11 AM EDT, 08/12/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were tracking higher late Tuesday morning, rising 0.30% to 1,491.18 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by medical device maker EAP TMS (EDAP) and furniture maker Natuzzi (NTZ), which advanced 8% and 5.8%, respectively. They were followed by biopharmaceutical companies Genfit ( GNFT ) and DBV Technologies ( DBVT ) , which rose 2.3%, each.

The decliners from continental Europe were led by software firm SAP (SAP) and semiconductor company Sequans Communications ( SQNS ) , which dropped 5.7% and 1.9%, respectively. They were followed by biotech firm Evaxion ( EVAX ) and financial services company Banco Bilbao Vizcaya Argentaria ( BBVA ) , which were down 1.2% and 1.1%, respectively.

From the UK and Ireland, the gainers were led by biotech firm Trinity Biotech ( TRIB ) and biopharmaceutical company NuCana ( NCNA ) , which surged 23% and 21%, respectively. They were followed by biopharmaceutical company Mereo BioPharma Group ( MREO ) and software firm Endava ( DAVA ) , which increased 7.2% and 3.7%, respectively.

The decliners from the UK and Ireland were led by biotech firm Autolus Therapeutics ( AUTL ) and biopharmaceutical company Adaptimmune Therapeutics ( ADAP ) , which shed 11% and 9.1%, respectively. They were followed by biopharmaceutical companies Akari Therapeutics ( AKTX ) and Amarin ( AMRN ) , which lost 2.9% and 1.1%, respectively.

Price: 1.40, Change: +0.14, Percent Change: +10.71